Literature DB >> 7557138

Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects.

R K Mittal1, R Holloway, J Dent.   

Abstract

BACKGROUND & AIMS: Low basal lower esophageal sphincter (LES) pressure is believed to be an important mechanism of reflux. The effects of atropine on the frequency and mechanisms of gastroesophageal reflux under the experimental conditions of a low basal LES pressure in 13 normal subjects were studied.
METHODS: LES pressure, esophageal pressures, esophageal pH, and crural diaphragm electromyogram were recorded simultaneously in the postprandial period for 30 minutes before and two 30-minute periods after the injection of atropine.
RESULTS: Atropine reduced the basal LES pressure from 16.4 +/- 3 to 8.7 +/- 2 mm Hg. The frequencies of reflux in the control and two postatropine periods were 3.5 +/- 0.5, 0.4 +/- 0.2, and 0.8 +/- 0.3, respectively (P < 0.05). The frequencies of transient LES relaxations decreased from 3.5 +/- 0.5 in the control to 0.4 +/- 0.2 and 1.5 +/- 0.4 in the two postatropine periods (P < 0.05). Transient LES relaxation and associated inhibition of the crural diaphragm was the major mechanism of reflux under conditions of low LES pressure induced by atropine.
CONCLUSIONS: Atropine-induced low LES pressure does not predispose to reflux in normal healthy subjects. Atropine reduces the frequency of reflux by its inhibitory effect on the frequency of transient LES relaxation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557138     DOI: 10.1016/0016-5085(95)90643-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  25 in total

Review 1.  Brain meets gut: gastroesophageal reflux.

Authors:  R F Pfeiffer
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

2.  Architecture and function of the gastroesophageal barrier in the piglet.

Authors:  Y Vicente; C Da Rocha; J Yu; G Hernandez-Peredo; L Martinez; B Pérez-Mies; J A Tovar
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

3.  Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism.

Authors:  J C Fang; I Sarosiek; Y Yamamoto; J Liu; R K Mittal
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

4.  Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans.

Authors:  J Boulant; S Mathieu; M D'Amato; A Abergel; M Dapoigny; G Bommelaer
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

5.  Characterization of the distal esophagus high-pressure zone with manometry, ultrasound and micro-computed tomography.

Authors:  A K Vegesna; J A Sloan; B Singh; S J Phillips; A S Braverman; M F Barbe; M R Ruggieri; L S Miller
Journal:  Neurogastroenterol Motil       Date:  2012-09-24       Impact factor: 3.598

6.  Treatment of GORD: Three decades of progress and disappointments.

Authors:  Jean Paul Galmiche; Frank Zerbib; Stanislas Bruley des Varannes
Journal:  United European Gastroenterol J       Date:  2013-06       Impact factor: 4.623

7.  Is glutamate involved in transient lower esophageal sphincter relaxations?

Authors:  D P Hirsch; G N J Tytgat; G E E Boeckxstaens
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

8.  Gastroesophageal reflux after combined lower esophageal sphincter and diaphragmatic crural sling inactivation in the rat.

Authors:  S Montedonico; J A Diez-Pardo; J A Tovar
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

9.  Atropine inhibits gastric distension and pharyngeal receptor mediated lower oesophageal sphincter relaxation.

Authors:  R K Mittal; C Chiareli; J Liu; R H Holloway; W Dixon
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

10.  Pharmacological dissection of the human gastro-oesophageal segment into three sphincteric components.

Authors:  James G Brasseur; Rhys Ulerich; Qing Dai; Dalipkumar K Patel; Ahmed M S Soliman; Larry S Miller
Journal:  J Physiol       Date:  2007-02-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.